Kurser indlæses...
Prognose
| Køb |
1 |
| Behold |
0 |
| Sælg |
0 |
Nyheder Til nyhedsfeedet
The Cannabist Company sells Virginia business to Curaleaf for $110 million
The Cannabist Company is selling its cannabis business in Virginia to a Curaleaf subsidiary for $110 million ( $80 million in cash, $20 million deferred, $10 million Schuldschein bearing 6% interest). The deal includes five active retail locations, one in development, and roughly 82,000 square feet of cultivation and production space near Richmond, and substantially exceeds the company’s current market capitalization. A special committee is reviewing additional strategic options; part of the proceeds will be used to repay outstanding notes. Closing is expected in early 2026, subject to regulatory approvals and a 15-day go-shop period. » Mere på de.investing.com
Cannabist Company reports revenue decline and falling EBITDA in Q3 2025
Cannabist Company posted a 7.5% revenue decline to $80m in Q3 2025 and adjusted EBITDA fell from $8.5m to $3m. Wholesale revenue contracted sequentially by 20%. Despite the weakness, the company generated positive free cash flow of $2.3m and ended the quarter with $17.8m in cash. Management formed a special committee to review strategic alternatives including asset sales and mergers; at the same time the company exited Florida and sold three locations in Pennsylvania while opening two new shops in Ohio. » Mere på de.investing.com
Cannabist Company reports revenue decline and share price loss due to restructuring
Cannabist Company Holdings Inc. reported a slight revenue decrease to 87 million US dollars and a lower gross margin for the second quarter of 2025, as the company undergoes a comprehensive restructuring and withdraws from several markets. Despite an improved EBITDA margin and a focus on core markets, the share price fell by 8.79% following the announcement of the results. Management emphasized the priority of cost savings and operational efficiency, but continues to face risks such as market saturation and regulatory changes. » Mere på de.investing.com
Virksomhedstal
| (EUR) | september 2025 | YoY |
|---|---|---|
| Omsætning | 68,1 mio. | - |
| Bruttofortjeneste | 19,52 mio. | - |
| Nettoresultat | -12,15 mio. | - |
| EBITDA | 6,65 mio. | - |
Fundamentale data
| Nøgletal | Værdi |
|---|---|
Markedsværdi | 12,92 mio. € |
Antal aktier | 497,46 mio. |
Højeste/laveste i 52 uger | 0,14 € - 0,0178 € |
| Udbytte | Nej |
Beta | 1,05 |
P/E (PE Ratio) | -0,15 |
PEG (PEG Ratio) | 0,00 |
K/I (PB Ratio) | -0,10 |
P/S (PS Ratio) | 0,09 |
Virksomhedsprofil
The Cannabist Company Holdings Inc. driver virksomhed inden for dyrkning, fremstilling og levering af cannabisprodukter og tilhørende tjenester i USA og internationalt. Virksomheden tilbyder et sortiment bestående af blomster, spiselige produkter, olier og tabletter under mærkerne Seed & Strain, Triple Seven, Hedy, gLeaf, Classix, Press og Amber. Den har licenser i 17 jurisdiktioner i USA. Virksomheden var tidligere kendt som Columbia Care Inc. og skiftede navn til The Cannabist Company Holdings Inc. i september 2023. Virksomheden blev grundlagt i 2012 og har hovedkvarter i New York, New York.
| Navn | Cannabist Co. Holdings Aktie |
| CEO | Christopher Marr |
| Hjemsted | Malvern,
pa USA |
| Websted | |
| Børsnotering | 29.04.2019 |
| Medarbejdere | 2.829 |
Tickersymboler
| Børs | Symbol |
|---|---|
Neo | CBST.NE |
Pnk | CBSTF |
Frankfurt | VW5.F |
Düsseldorf | VW5.DU |
München | VW5.MU |